Searching for the Next PD-L1 Caliber Companion Dx Assay? Follow These Steps.
A Case Study in Multi-Assay Immunomodulatory Receptor Evaluation Across Matched Biospecimens
Transcriptome analyses of whole blood samples from normal healthy control subjects and patients with Parkinson’s
Evaluation of Immunomodulatory Receptor/Ligand Expression on Matched Human Biospecimens
Utility of Biomarkers to Differentiate Adenocarcinoma Of The Uterine Cervix from Its Mimics
Laying the foundation for the successful 22C3 PD-L1 companion diagnostic assay
Utilization of a single strategic partner for biospecimens and genomic services
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinomas Show a Marked Increase in PDL1 Expression Relative to Viral Negative Tumors
Multiparametric Flow Analysis of IMRs in Matched Tumor and Blood Biospecimens
Custom Sourcing for a 30 Patient, Matched Monocytes and Pan T-cells Study
Development of a 100 Patient, Multi-Indication Tumor Cell Isolation Cohort for a Biomarker Discovery Study
T Cell Expansions with Custom Flow Analysis and Patient-Matched Primary T Cells
Multi-Parametric Flow Cytometry Analysis of Checkpoint Inhibitors (PD-1 and PD-L1) in Dissociated Tumor and Normal Tissues
Large-Scale Cohort Development Supporting Companion Dx and IO Biomarker Discovery
March 10, 2019
December 10, 2018
Exploring Dissociated Human Tissues as an Alternative to Fresh Tissue for Multiple Downtstream Applications
Mediators of the Immune Response
August 14, 2018
August 17, 2017
Discovery Life Sciences advances science in an innovative, collaborative, and client-centric environment. We are grounded in a “Science at your Service” attitude.
Learn More »
Discovery Life Sciences provides the world class biospecimen analysis and procurement needed to advance modern drug and biomarker discoveries.
Terms & Conditions » Biospecimen Purchase Agreement » Data Use Agreement »
Leading Research Sample bioBank with online easy-ordering for Human Biospecimens and Immediate Overnight Delivery
Terms & Conditions »
T: +01 (866) 838-2798 E: email@example.com
© 2020 Discovery Life Sciences.
All Rights Reserved.
Checkpoint Inhibitor Therapy Utilization and PD1/PDL1 Expression Across a Global Clinical Network.
Put Discovery Partners® to Work for You
The Discovery Partners platform is a global, integrated network. We collaborate with these clinical partners to fulfill human biospecimen research needs.
firstname.lastname@example.org (866) 838-2798